Platelet-activating factor acetylhydrolase: ICOS began a Phase I trial

ICOS Corp. (ICOS), Seattle, Wash. Product: Platelet-activating factor acetylhydrolase (PAF-AH) Indication: Inflammatory disorders Status: ICOS began a Phase I trial with its recombinant form of the hu...